|
Vol. 36 Nş 6 |
Lat. Am. J. Pharm. 36 (6): 1061-1272 (2017) |
REGULAR ARTICLES |
|
|
Ovarian Cancer Treatment Drug 13-Cis Retinoic Acid Showed Inhibition on the Activity of UDP-Glucuronosyltransferases (UGTs) *
ZOU Y., WANG Z., ZHENG X., WU J. & HUANG Y. (1067)
|
|
|
|
Cardiovascular Treatment Drug Prasugrel Inhibited the Metabolism of Irinotecan During the Treatment of Old People Diseases *
WU H. & LI K. (1072)
|
|
|
|
Comparison of the Inhibition of Herbal Ingredients Praeruptorin A and B Towards the Metabolism of Serotonin *
LIU J., JIANG Y., ZHOU Y., WANG D., LIANG X. & YI M. (1077)
|
|
|
|
A LC-MS/MS Method for Simultaneous Quantification of Levodopa and Istradefylline for Parkinsons Disease and Application to a Pharmacokinetic Study *
WANG L., ZHANG Q., ZENG T., YE T., ZHOU L., DING S. & WANG X. (1081)
|
|
|
|
Vemurafenib Disrupted the Metabolism of Drugs Treating Chronic Obstructive Pulmonary Diseases (COPD) *
ABUDOUKELIMU M., YAN F., LEI L. & GUO Y. (1088)
|
|
|
|
In Silico Prediction of Drug-Drug Interaction between Vemurafenib and Drugs to Treat Rheumatism *
CUI Y., & LI Y. (1092)
|
|
|
|
Preparation and In Vitro/In Vivo Evaluation of Rofecoxib Containing Bovine Serum Albumin Microspheres *
DEMIRTURK E., GULSUN T., CAYLI Y.A., IZAT N., SAHIN S. & ONER L. (1096)
|
|
|
|
Metformin Strengthens the Inhibition Potential of Sulfonylureas Towards the Activity of Carboxylesterases (CES) *
LIU C., YANG X., TIAN Y., LI W., GAO D. & MA H. (1105)
|
|
|
|
Taste Masking and Evaluation of Oral Disintegrating Tablet of Gatifloxacin Using Ion-Exchange Resins *
LIU H., ZHU F., HE Y., RUAN X., QU Y., LIANG C., CHEN C., XU Y., & PAN W. (1108)
|
|
|
|
Effect of Thiamine Pyrophosphate on Oxidative Damage to the Oropharyngeal, Nasal and Cochlear Tissues Induced by Doxorubicin in Guinea Pigs *
ERHAN E., TURAN F., TERZİ S., CELİKER M., MAMMADOV R., MALKOC I., KUKULA O. & CANKAYA M. (1115)
|
|
|
|
In Silico Prediction of Retinoic Acids Binding with Drug-Metabolizing Enzymes Involved in the Metabolism of Ear or Nose or Throat Diseases Treatment Drugs *
WANG C., & WANG C. (1123)
|
|
|
|
Fucoidan Induce Apoptosis of HeLa Cells Accompanied by The Induction of Autophagy *
LI X., YANG L., WANG Y., LIANG H., SONG S. & JI A.G. (1126)
|
|
|
|
The Inhibition of Dabrafenib Towards Zidovudine Metabolism and Mechanism Analysis *
SUN Z., CUI X., ZHAO Z. & ZENG R. (1134)
|
|
|
|
Potential Drug-Drug Interaction Between Retinoic Acid and Drugs Employed to Treat Children Epilepsy *
YANG, A. & YU, H. (1139)
|
|
|
|
Investigation of the Inhibition of UDP-Glucuronosyltransferases (UGTs) by Retinoic Acid and Retinaldehyde *
SUN X., CAO Y., FU Z., & LI Q. (1142)
|
|
|
|
Synthesis, Crystal Structure and Anti-Inflammatory Activity in Rachitis of a New Zn(II) Coordination Compound *
TANG, Y. & ZHANG M. (1147)
|
|
|
|
Biowaiver Evidence for Ketorolac Tromethamine Immediate-Release Tablets *
JUNG-COOK H., MAYET-CRUZ L., RUBIO-CARRASCO K. & GIRARD-CUESY M.E. (1151)
|
|
|
|
Evaluation of Clinical Pharmacists Interventions in a Specialized Cardiac Center: Impact on Patients Direct Medication Cost *
ALMITWAZI A.A., KHURSHID F.M., ALKHODAIR A.M., ALMUTAIRI M.A. & ALSULTAN M.S. (1157)
|
|
|
|
Prevalence of Multidrug-Resistance and Extensively-drug Resistance in Gram-Negative Clinical Isolates from Outpatients *
FATIMA S., MUHAMMAD I.N., USMAN S. & JAMIL S. (1164)
|
|
|
|
Synthesis and Biological Activities of Metal Complexes with Schiff Base Ligand Derived from Imidazole-2-Carboxaldehyde and Ethylenediamine *
WANG C., WU C., FENG P., HUANG Y., ZHANG J. & YANG X. (1169)
|
|
|
|
Different Drug-Drug Interaction Results Between 13-Cis Retinoic Acid and Irinotecan in Patients with Different Glutamic-Oxalacetic Transaminase Activity *
CHEN J. & LI X. (1177)
|
|
|
|
Pharmacokinetics and Pharmacodynamics Interaction of Warfarin in the Presence of Beverage Juices (Licorice and Pomegranate) in Rat Plasma by Using LC/MS *
MIMA M., MALLAH E., ABUDAYYIH W., ELHAJJI F.D., SALIH H., ZAKARAYA Z., OTHMAN B., & ARAFAT T. (1181)
|
|
|
|
Determination and Pharmacokinetic Study of Synephrine in Rat by UPLC-MS/MS After Intravenous Administration *
XIE H., WANG Z., WANG Q., ZHANG J., CHEN J., DONG Y., ZHOU H., CHEN D., WANG S. & ZHOU Y. (1193)
|
|
|
|
Quantitation of Skullcapflavone-II in Dog Plasma and its Application to Pharmacokinetic Studies *
CHEN P., LIU S., JI W., CAO S., DAI G., ZHANG L. & JU W. (1198)
|
|
|
|
Determination and Pharmacokinetic Study of Daurisoline in Rat Plasma by UPLC-MS/MS *
JIN Y., SONG C., SHAO L., WANG L., TU X., CHEN B., CHEN J., ZHI Y., WEN C. & ZHU W. (1204)
|
|
|
|
Incidence of Potential Drug-Drug Interactions in Patients with Cardiovascular Complications Due to the Trend of Polypharmacy Prescription in Pakistan *
JAVAID F., HANIF S., SYED M.A., JAWAD S., AFZAL S., MALIK R., ASHRAF S. & KHAN I. (1210)
|
|
|
|
Lipidomics Method to Elucidate the Therapeutic Function and Carboxylesterase (CES)-Based Clinical Drug Interaction of Fufang Buguzhi Keli, a Traditional Chinese Medicine, Towards Human Osteoporosis *
WANG, X. (1218)
|
|
|
|
Synthesis, Crystal Structure and Anti-Liver Tumor Activity of a Novel Inorganic-Organic Hybrid Supramolecular Compound *
LUO E., ZHANG W., SONG X., & GAN J. (1223)
|
|
|
|
Inhibition of Intestinal UDP-Glucuronosyltransferase (UGT) 1A7 and 1A10 by Ovarian Cancer Treatment Drug *
LI H., WANG H., YU X. & DU X. (1227)
|
|
|
|
Pharmacokinetic study of Syringin in Rat by Ultra-Performance Liquid-Chromatography Tandem Mass Spectrometry *
HU L., LIN G., ZHANG M., WANG J., WANG S. & WANG B. (1231)
|
|
|
|
Lignans from Trachelospermum jasminoides and Synergistic Antifungal Activity *
GUO L., XU L., ZHENG W., DONG J., YI X. & JIN Y. (1236)
|
|
|
|
Expanded Program on Immunization (EPI) Cold Chain Practices Assessment in Pakistan *
KHAN A., ZAMAN S., AFZAAL H., TARIQ M.H., KHAN T.M. & BUKHSH A. (1241)
|
|
|
|
Determination of Esculentoside A in Rat Plasma by UPLC-MS/MS and Applied to a Pharmacokinetic Study *
REN K., QIAN S., TU X., PENG X., CHEN W., LIN G., WANG J., MA J., ZHANG Z., WEN C. & WANG Y. (1245)
|
|
|
|
Ovarian Cancer Treatment Drug Everolimus Inhibits the Metabolic Elimination of First-Line Anti-Colon Cancer Irinotecan *
WANG H., LI H., ZHANG Q. & ZHAO D. (1250)
|
|
|
|
Two Novel Biscoumarins as Traditional Chinese Medicines: Crystal Structure and Anti-Gastrointestinal Cancer Activity *
LIU X., SHEN Y., ZHAO S. & ZHU X. (1255)
|
|
|
|
Brain Protective Drug Nimodipine Influences the Metabolic Elimination of Irinotecan *
LI Z. (1260)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|